BPC 157 was added into each well at the concentration of 0 (control group), 0.1, 0.25 and 0.5 g/mL for 1, 2, and 3 days at 37 C in a humidified atmosphere of 5% CO 2 /95% air
The FDA lists BPC-157 among bulk drug substances that may present significant safety risks in compounding, citing concerns such as immune reactions, peptide-related impurities, and limited safety information
During the first 2-3 weeks of BPC-157 treatment, minimize repetitive wrist motions and activities that reproduce pain
Before you scoop, check out the Quality Concerns section of our Protein Powders, Shakes, and Meal Replacements Review, which includes our Top Picks for protein
Proper disposal practices maintain clean and safe working environments
Your prescription label specifies the exact volume